MicheleHensonMDMHSc

PubMed

• 18 citations
  30-Year Review of Pediatric- and Adult-Onset CVID: Clinical Correlates and Prognostic Indicators
  Carolyn H. Baloh, Anupama Reddy, Michele R. Henson, Katherine Prince, Rebecca H. Buckley, Patricia L. Lugar> ;Journal of Clinical Immunology. 2019 Aug 3
• 9 citations
  The future of food allergy therapeutics.
  Michele R. Henson, A. Wesley Burks> ;Seminars in Immunopathology. 2012 Jun 27

Journal Articles

• The Future of Food Allergy Therapeutics  
  Henson M and Burks AW, Seminars in Immunopathology, 1/1/2012
• Future Therapies for Food Allergies – CME Examination  
  Chin S, Henson M, McWilliams L, Mousallem T, Shah A, Wu E, Boden SR, Burks AW, J of Allergy Clin Immunol, 1/1/2011

Abstracts/Posters

• The Duke University Medical Center (DUMC) Experience with Common Variable Immune Deficiency (CVID)
  Henson M, Buckley R, Lugar P, American Academy of Allergy, Asthma, and Immunology Annual Meeting. San Antonio, TX, 2/1/2013
• Exome Sequencing Reveals Novel Genetic Underpinnings of Common Variable Immune Deficiency
  Lugar P, Henson M, Love C, Gutekunst H, Sun Z and Dave Sl, American Academy of Allergy, Asthma and Immunology Annual Meeting, Featured Poster. San Antonio, TX, 2/1/2013
• Peanut Oral Immunotherapy and Omalizumab Treatment for Peanut Allergy
  Henson M, Edie A, Steele P, Kamilaris J, Kulis M, Thyagarajan A, Vickery BP and Burks AW, American Academy of Allergy, Asthma, and Immunology Annual Meeting. Orlando, FL, 3/1/2012
• Efficacy of Omalizumab in a University Allergy Practice
  Lemke M, Henson M, Fahrenholz J, American Academy of Allergy, Asthma, and Immunology Annual Meeting. Washington, D.C., 3/1/2009
• Join now to see all

Lectures

• The Duke University Medical Center (DUMC) Experience with Common Variable Immune Deficiency (CVID) 
  Duke University Clinical Research Training Program Oral Defense - 4/1/2013
• The Future of Food Allergy Therapeutics 
  Wake Forest School of Medicine. Pulmonary/Allergy/Immunology Division Conference - 1/1/2013
• FPIES: Food Protein-Induced Enterocolitis Syndrome 
  Duke University Allergy/Immunology Division Conference - 6/1/2011
• Efficacy of Omalizumab in a University Allergy Practice 
  Cincinnati Children's Allergy/ Immunology Division Conference - 1/1/2009
• Join now to see all